^
2d
Polystyrene nanoplastics exacerbate dibutyl phthalate-induced liver fibrosis through PDGFRα-dependent hepatic stellate cell activation. (PubMed, Environ Pollut)
In vivo, both PDGFRα antibody neutralization and pharmacological inhibition with imatinib significantly attenuated DBP-induced hepatic fibrosis and inflammatory gene expression, confirming PDGFRα's central role in DBP toxicity...Collectively, these findings identify PDGFRα as a mechanistic nexus linking DBP and PS-NPs exposure to hepatic fibrosis and highlight its potential as a therapeutic target for environmentally induced liver disease. The results further underscore the importance of co-exposure paradigms in evaluating the health risks of complex contaminant mixtures.
Journal
|
PDGFRA (Platelet Derived Growth Factor Receptor Alpha) • IL6 (Interleukin 6) • ACTA2 (Actin Alpha 2 Smooth Muscle) • TGFB1 (Transforming Growth Factor Beta 1) • COL1A1 (Collagen Type I Alpha 1 Chain)
|
imatinib
2d
New P1/2 trial
|
ABL1 (ABL proto-oncogene 1) • CD19 (CD19 Molecule)
|
ABL1 T315I • ABL2 fusion
|
cytarabine • Blincyto (blinatumomab) • vincristine • Scemblix (asciminib)
3d
New trial
|
ABL1 (ABL proto-oncogene 1)
|
Nailike (olverembatinib)
5d
Multiomics analysis reveals that senescent CXCL16+ macrophages promote lung adenocarcinoma progression through TGF-β signalling. (PubMed, J Transl Med)
CXCL16 promotes macrophage senescence, and senescent CXCL16+ macrophages drive LUAD progression through TGF-β signalling. These findings identify CXCL16+ macrophages as a biologically and therapeutically relevant immune cell population, highlighting a potential target for precision intervention in LUAD.
Journal • IO biomarker
|
TGFB1 (Transforming Growth Factor Beta 1) • CDKN1A (Cyclin-dependent kinase inhibitor 1A) • CXCL16 (C-X-C Motif Chemokine Ligand 16)
|
bosutinib
5d
Relapse of chronic myeloid leukemia presenting with blurred vision after allogeneic hematopoietic stem cell transplantation (PubMed, Rinsho Ketsueki)
Betamethasone and levofloxacin ophthalmic solutions were started on the same day. Molecular remission was achieved on day 161 after relapse. Three years later, the patient remains in remission on dasatinib therapy.
Journal
|
ABL1 (ABL proto-oncogene 1)
|
dasatinib
6d
μPharma: A microfluidic, AI-driven pharmacotyping platform for single-cell drug sensitivity prediction in leukemia. (PubMed, Med)
μPharma provides rapid (4-h assay), accurate, and automated prediction of drug sensitivity at single-cell resolution using minimal clinical samples, potentially enabling same-day precision oncology decision-making.
Journal • IO biomarker
|
BCL2 (B-cell CLL/lymphoma 2)
|
Venclexta (venetoclax) • dasatinib
7d
Observational Study on Dose Optimization of Olverembatinib in Patients with Chronic Myeloid Leukemia in Chronic or Accelerated Phase (ChiCTR2500115245)
P=N/A, N=100, Not yet recruiting, Peking University People's Hospital; Peking University People's Hospital
New trial
|
ABL1 (ABL proto-oncogene 1)
|
Nailike (olverembatinib)
7d
Asciminib real world study (ChiCTR2600116168)
P4, N=200, Recruiting, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology; Union Hospital, Tongji Medical College, Huazhong University o
New P4 trial
|
ABL1 (ABL proto-oncogene 1) • BCR (BCR Activator Of RhoGEF And GTPase)
|
Scemblix (asciminib)
7d
VOP regimen for the treatment of adult de novo Ph+ B/myeloid mixed phenotype acute leukemia (ChiCTR2500112802)
P2, N=10, Not yet recruiting, The First Affiliated Hospital, College of Medicine, Zhejiang University; The First Affiliated Hospital, College of Medicine, Zhejiang University
New P2 trial
|
Venclexta (venetoclax) • Nailike (olverembatinib)
7d
Targeting senescent cells in aged adipose tissue induced by ovarian cancer with the NF-κB inhibitor quercetin and resveratrol impedes the growth and metastasis of ovarian cancer. (PubMed, Sci China Life Sci)
Both treatment with the senolytic cocktail dasatinib plus quercetin and treatment with the NF-κB inhibitor resveratrol (RSV) alleviated adipose tissue ageing, improved glucose tolerance and insulin sensitivity, and ultimately decreased OC progression and metastasis. Together, these results indicate an important role of ovarian cancer in adipose tissue ageing, and identify the elimination of senescent ADSCs in adipose tissue as a new potential strategy for the treatment of OC.
Journal
|
IL18 (Interleukin 18) • IL1B (Interleukin 1, beta)
|
dasatinib
8d
Intra-abdominal Desmoid Tumors Mimicking Gastrointestinal Stromal Tumor (GIST) Recurrence: A Case Report. (PubMed, Cureus)
We report a case of a 60-year-old male who developed intra-abdominal desmoid tumors five years after undergoing laparoscopy and endoscopy cooperative surgery (LECS) for gastric GIST, followed by adjuvant imatinib therapy...Histopathological confirmation remains crucial for accurate diagnosis. Surgical resection is the primary treatment for symptomatic desmoid tumors, but given their high recurrence rate, long-term follow-up and a multidisciplinary approach are essential for optimal management.
Journal
|
KIT (KIT proto-oncogene, receptor tyrosine kinase) • CTNNB1 (Catenin (cadherin-associated protein), beta 1) • CD34 (CD34 molecule)
|
imatinib
8d
New trial • Real-world evidence
|
ABL1 (ABL proto-oncogene 1) • BCR (BCR Activator Of RhoGEF And GTPase)
|
Scemblix (asciminib)